Covidh Technologies Ltd

📈 Covidh Technologies Expands into Pharma & Life Sciences with Strategic Acquisition

- Acquisition of 100% equity shareholding of iSERA Biological Limited through a share swap

- Total consideration: ₹78,00,10,960

- Issuance of up to 1,61,82,800 equity shares at ₹48.20 per share

- Share swap ratio: 1:1 (one iSERA Lifesciences share for each iSERA Biological share)

- Authorized share capital to increase from ₹11 crore to ₹25 crore

- Aims to expand presence in pharmaceutical and life sciences sector

- Upon completion, iSERA Biological will become a wholly owned subsidiary